PanGen Biotech Inc. (KOSDAQ:222110)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,980.00
-60.00 (-0.99%)
At close: Aug 28, 2025

PanGen Biotech Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
80,69573,52073,46269,40599,78397,864
Upgrade
Market Cap Growth
46.29%0.08%5.85%-30.44%1.96%30.63%
Upgrade
Enterprise Value
64,53469,81474,76767,44692,63896,121
Upgrade
Last Close Price
5980.005700.006880.006500.009350.0010150.00
Upgrade
PE Ratio
32.3077.91----
Upgrade
Forward PE
-91.3091.3091.3091.3091.30
Upgrade
PS Ratio
5.095.0110.0410.6812.5715.81
Upgrade
PB Ratio
2.742.955.854.034.736.89
Upgrade
P/TBV Ratio
2.813.056.294.104.807.02
Upgrade
P/FCF Ratio
19.2627.99----
Upgrade
P/OCF Ratio
17.0024.61----
Upgrade
EV/Sales Ratio
4.074.7610.2210.3811.6715.53
Upgrade
EV/EBITDA Ratio
15.9428.06----
Upgrade
EV/EBIT Ratio
24.9268.43----
Upgrade
EV/FCF Ratio
15.4026.58----
Upgrade
Debt / Equity Ratio
0.030.030.1600.891.30
Upgrade
Debt / EBITDA Ratio
0.220.33----
Upgrade
Debt / FCF Ratio
0.210.31----
Upgrade
Asset Turnover
0.510.570.350.200.200.16
Upgrade
Inventory Turnover
1.241.480.941.071.822.12
Upgrade
Quick Ratio
4.254.980.421.551.280.97
Upgrade
Current Ratio
6.107.161.727.591.571.20
Upgrade
Return on Equity (ROE)
9.92%5.04%-30.14%-23.46%-18.75%-26.69%
Upgrade
Return on Assets (ROA)
5.21%2.49%-12.75%-8.97%-5.17%-6.13%
Upgrade
Return on Capital (ROIC)
6.55%3.16%-16.61%-10.06%-5.68%-6.76%
Upgrade
Return on Capital Employed (ROCE)
8.00%3.70%----
Upgrade
Earnings Yield
2.85%1.28%-6.11%-6.48%-3.32%-4.45%
Upgrade
FCF Yield
5.19%3.57%-5.27%-6.10%-4.76%-5.56%
Upgrade
Buyback Yield / Dilution
-13.67%-7.03%-0.13%-4.47%-6.02%0.04%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.